Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
04/02/1991 | US5004688 Purification of hepatitis proteins |
04/02/1991 | US5004608 Amebiasis vaccine |
04/02/1991 | US5004607 Method of immunizing poultry |
04/02/1991 | US5004604 Incubating animal cells with antibodies which coat them, washing, injecting into animal, collecting blood, separating serum |
03/30/1991 | WO1991005258A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
03/30/1991 | WO1991005055A1 Method for the preparation of an immunizing composition |
03/30/1991 | WO1991005049A1 A recombinant birth control vaccine |
03/30/1991 | CA2067172A1 Process for preparing an immunizing composition |
03/30/1991 | CA2066674A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
03/30/1991 | CA2066197A1 Recombinant birth control vaccine |
03/30/1991 | CA2026508A1 Stable immunogen composition for oral administration |
03/28/1991 | WO1991004745A1 Compositions for cell adhesion inhibition and methods of use |
03/28/1991 | CA2067183A1 Compositions for cell adhesion inhibition and methods of use |
03/28/1991 | CA2026283A1 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
03/27/1991 | EP0419446A1 A complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
03/27/1991 | EP0419387A1 Hydrophilic derivatives, diagnostic and therapeutic applications, kits and immunological reagents |
03/27/1991 | EP0419292A1 Human tryptase-like protein |
03/27/1991 | EP0419238A1 Antibodies and proteins |
03/27/1991 | EP0419182A1 New HCV isolates |
03/27/1991 | EP0418827A1 Vaccine against Lyme disease |
03/27/1991 | EP0418626A2 Fused proteins and production thereof |
03/27/1991 | EP0418590A1 Antibodies, production thereof and use |
03/27/1991 | EP0418347A1 Human monoclonal antibodies to human immunodeficiency virus |
03/27/1991 | EP0418316A1 Platelet-specific chimeric immunoglobulin |
03/27/1991 | EP0418283A1 Antibodies |
03/26/1991 | US5003058 DNA coding for antigen protein of rinderpest virus |
03/26/1991 | US5003048 Solvent extraction to isolate lymphokines used as antitumor agents |
03/26/1991 | US5002884 Immobilization of physiologically active substances on an inorganic support |
03/26/1991 | US5002878 Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses |
03/26/1991 | US5002869 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes |
03/26/1991 | CA1282069C Antibody complexes of hapten-modified diagnostic or therapeutic agents |
03/26/1991 | CA1282021C Particulates having the immunogenic power of the hbs antigen and carrying an antigenic site foreign to the epitopes carried by the hbs antigen; vectors and animal cells for the production of such particulates and compositions containing such particulates for the production of mixed vaccines |
03/26/1991 | CA1282003C Vaccine formulation |
03/26/1991 | CA1282001C Immunoselection method |
03/26/1991 | CA1282000C Immunoselection method |
03/24/1991 | WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
03/24/1991 | CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks |
03/24/1991 | CA2025942A1 Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays |
03/23/1991 | WO1991004273A2 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
03/23/1991 | WO1991004052A1 Vaccines |
03/23/1991 | CA2066653A1 Vaccines |
03/23/1991 | CA2066607A1 Peptides associated with the cd4 binding region of gp120 and their methods of use |
03/23/1991 | CA2025630A1 Human tryptase-like protein |
03/21/1991 | WO1991004045A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
03/21/1991 | WO1991003556A1 Recombinant product |
03/21/1991 | WO1991003552A1 Recombinant negative strand rna virus expression systems and vaccines |
03/21/1991 | WO1991003257A1 Methods for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
03/21/1991 | WO1991003255A1 Polypeptide vaccines against foot-and-mouth disease virus |
03/21/1991 | WO1991003252A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
03/21/1991 | CA2065402A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
03/21/1991 | CA2025684A1 Antibodies and proteins |
03/21/1991 | CA2025263A1 Complex suitable for carrying out a method of purifying pre-s hepatitis b surface antigen |
03/20/1991 | WO1991004336A1 Method for improving human monoclonal antibody production |
03/20/1991 | EP0418143A1 Dicarboxylic acids derivatives containing a nitrogen or oxygen heteroring, process for their preparation and their use as medicines |
03/20/1991 | EP0417927A1 Detection and treatment of infections with immunoconjugates |
03/20/1991 | EP0417524A1 Antigens and polypeptides derived from babesia (12D3 antigen) |
03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
03/20/1991 | EP0417196A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |
03/20/1991 | EP0417188A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
03/20/1991 | EP0417168A1 Antibodies to human mammary cell growth inhibitor and methods of production and use |
03/20/1991 | EP0172865B1 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
03/20/1991 | CN1050044A Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders |
03/20/1991 | CA2066720A1 Method for improving human monoclonal antibody production |
03/20/1991 | CA2025634A1 Peptides including ctl epitopes of hiv proteins and use thereof |
03/20/1991 | CA2025481A1 Vaccine for aids and hepatitis b |
03/19/1991 | US5001225 Monoclonal antibodies to a pan-malarial antigen |
03/19/1991 | US5001056 Linking proliferating cells and B-cells through antigens and surface immunoglobulins, fusing |
03/19/1991 | US5001052 Immunoassay for FHAP and antibody useful therewith |
03/19/1991 | US5000952 Polypeptide pertussis toxin vaccine |
03/19/1991 | US5000951 Multivalent canine distemper virus vaccine |
03/19/1991 | CA2025577A1 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
03/19/1991 | CA1281849C Solubilization of protein aggregates |
03/16/1991 | WO1991004316A2 Ciliary neurotrophic factor |
03/16/1991 | WO1991004262A1 New hcv isolates |
03/16/1991 | CA2040404A1 Ciliary neurotrophic factor |
03/15/1991 | WO1991004317A1 Method for the production of in vitro expanded lymphoid cells for use in adoptive immunotherapy |
03/15/1991 | WO1991004059A2 Method and useful apparatus for preparing pharmaceutical compositions |
03/15/1991 | WO1991004050A1 Therapeutic compositions; methods for treatment of hiv infections |
03/15/1991 | CA2067158A1 Method and useful apparatus for preparing pharmaceutical compositions |
03/15/1991 | CA2066645A1 Method for the production of in vitro expanded lymphoid cells for use in adoptive immunotherapy |
03/15/1991 | CA2065029A1 Therapeutic compositions; methods for treatment of hiv infections |
03/14/1991 | CA2025230A1 Treponema hyodysenteriae antigens having a molecular weight of 39 kda and dna encoding therefor |
03/13/1991 | WO1991004320A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
03/13/1991 | EP0416816A1 Hyposensitization agent |
03/13/1991 | EP0416725A2 Blood-borne non-A, non-B hepatitis specific protein, DNA encoding it, and process for its production |
03/13/1991 | EP0415929A1 Heteroligating antibodies and therapeutic uses thereof |
03/13/1991 | EP0185762B1 Cell-delivery agent |
03/13/1991 | CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
03/13/1991 | CA2025036A1 Dicarboxylic derivatives comprizing a nitrogenous or oxygenous heterocycle, process for their preparation and use as medicaments |
03/12/1991 | US4999421 HTLV-I anti-sense RNA and encoded proteins |
03/12/1991 | US4999296 Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same |
03/12/1991 | US4999191 For poultry, mutant strain |
03/12/1991 | CA1281287C Protection of equines against streptococcus equi |
03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
03/09/1991 | CA2024918A1 Fused proteins and production thereof |
03/08/1991 | WO1991003259A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
03/08/1991 | CA2066244A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
03/08/1991 | CA2005917A1 Method for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
03/07/1991 | WO1991002819A1 Recombinant japanese encephalitis molecules and methods of use therefor |